The MADI plication - a revised technique

Article

A comparison study of patients who underwent minimally invasive strabismus surgery (MISS) with a total dissection of the plicated part of the rectus muscle and those who had MISS where only a marginal dissection was performed.

Surgical techniques for reducing the conjunctival incision size in minimally invasive strabismus surgery (MISS) have been developed (see New MISS technique is a hit) helping to drastically reduce tissue trauma and postoperative discomfort for patients. Over the years strabismologists have used a number of access techniques for horizontal muscle recession, plication or resection.1-5

"I wanted to find a new, even less traumatic minimally invasive plication technique using no spatula, compared to the standard MISS procedure," explained Dr Mojon. "So, rather than undertake a total dissection (TODI) I performed only a marginal dissection (MADI) of the plicated part of the muscle."

The study

Exclusions

For those who underwent both MADI and TODI plication but who required revision surgery or retroequitorial fixation sutures, vertical rectus muscle surgery or simultaneous surgery of an oblique muscle were excluded.

Follow-up

Orthoptic examinations were conducted postoperatively on Day 1 and after 6 months for both groups of patients. Only those with a complication or not referred by an ophthalmologist were seen at Dr Mojon's department. The remainder were followed up by referring ophthalmologists in between Day 10 and Week 4.

Measured outcomes

"The outcomes examined included alignment, vision variations, binocular single vision, refraction, conjunctival abnormalities, dose-response relationship and number and types of complications experienced during the six months following the operation," said Dr Mojon.

The modified technique for MADI MISS

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.